Roche Glycart AG

Where the EU money came from

Funding by EU programme. Amounts are Roche Glycart AG's own share of each project, not the project's full budget.

Projects

3 EU-funded projects, newest first. Each links to the official record.

• T-RAFICAssociated partner

  Training network for tracking and controlling therapeutic immune cells in cancer

  Horizon Europe · 2025–2029 · Project on CORDIS ↗
• TOP-GUTAssociated partner

  Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract

  Horizon Europe · 2023–2027 · Project on CORDIS ↗
• T-OPPartner

  Training Network for Optimizing Adoptive T cell Therapy of Cancer

  Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  €281ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Kobenhavns UniversitetDenmark · 2 shared projects
• Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
• Danmarks Tekniske UniversitetDenmark · 2 shared projects
• Ludwig-Maximilians-Universitaet MuenchenGermany · 2 shared projects
• Universitetet i OsloNorway · 2 shared projects
• Stichting Amsterdam UmcNetherlands · 2 shared projects
• Region HovedstadenDenmark · 2 shared projects
• Universite Paris-SaclayFrance · 2 shared projects
• Universita Della Svizzera ItalianaSwitzerland · 2 shared projects
• Fondazione Per L'Istituto di Ricerca In BiomedicinaSwitzerland · 2 shared projects
• Miltenyi Biotec BV & Co KGGermany · 2 shared projects
• Technische Universitaet MuenchenGermany · 1 shared project
• Universiteit UtrechtNetherlands · 1 shared project
• Universitair Medisch Centrum UtrechtNetherlands · 1 shared project
• Charite - Universitaetsmedizin BerlinGermany · 1 shared project
• Technische Universitat BerlinGermany · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• drug discovery
• immunotherapy
• inflammatory diseases
• oncology
• personalized medicine
• stem cells